Instylla
PrivateLast Round
Series B
Extension
Aug 15, 2023
Est. Valuation
$125.43M
Total Funding Raised
$75.96M
Momentum Score
50 /100
Company Overview
Instylla is a medical device company that develops liquid embolic solutions for interventional radiology, aimed at providing controlled and effective embolization to enhance patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Instylla Comps
Public and private peers based on sector, stage, and business model.
Instylla Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Aug 15, 2023 | ||||
| Series B | Oct 14, 2020 | ||||
| Debt | Apr 28, 2020 | ||||
| Series A Extension | Jun 26, 2018 | ||||
| Series A | May 23, 2017 |
Instylla Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Incept LLC | Series B Extension, Series A |
| Ascension Ventures | Series B Extension, Series A, Series B |
| CHV | Series B Extension, Series B |
| Incept AI | Series B Extension, Series B |
| Sparta Group LLC | Series B |
| Catalyst Health Ventures | Series B Extension, Series B |
| Excelestar Ventures | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Embrace(TM) Hydrogel Embolic System approved for tumor embolization.
- Jan 1, 2026
Embrace(TM) Hydrogel Embolic System approved for tumor embolization.
Instylla Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Instylla's valuation, stock price, and market status.
